These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 34514203)
21. The transition of renal histopathology after immunosuppressive therapy in a woman with renal limited ANCA-associated vasculitis: a case report and literature review. Li XY; Liang YS; Pai P Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S115-20. PubMed ID: 26841801 [TBL] [Abstract][Full Text] [Related]
22. The role of mammalian target of rapamycin pathway in the pathogenesis of pauci-immune glomerulonephritis. Soypacaci Z; Cakmak O; Cakalagoglu F; Gercik O; Ertekin I; Uzum A; Ersoy R; Akar S Ren Fail; 2019 Nov; 41(1):907-913. PubMed ID: 31658846 [No Abstract] [Full Text] [Related]
23. Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Gigante A; Salviani C; Giannakakis K; Rosato E; Barbano B; Moroso A; Gasperini ML; Nofroni I; Salsano F; Cianci R; Pugliese F Int J Immunopathol Pharmacol; 2012; 25(1):287-92. PubMed ID: 22507343 [TBL] [Abstract][Full Text] [Related]
24. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Shah S; Havill J; Rahman MH; Geetha D Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939 [TBL] [Abstract][Full Text] [Related]
25. Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors. Oudah N; Al Duhailib Z; Alsaad K; Qurashi S; Ghamdi G; Flaiw A; Hejaili F; Farooqui M; Al Sayyari A Clin Exp Med; 2012 Jun; 12(2):121-5. PubMed ID: 21706346 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological Characteristics and Outcomes of Diffuse Crescentic Glomerulonephritis - A Single Center Experience from Southern India. Nagaraju SP; Laxminarayana SLK; Kosuru S; Parthasarathy R; Attur RP; Rangaswamy D; Matteti UV; Guddattu V J Clin Diagn Res; 2017 Sep; 11(9):OC21-OC24. PubMed ID: 29207754 [TBL] [Abstract][Full Text] [Related]
28. Crescentic glomerulonephritis: a clinical and histomorphological analysis of 46 cases. Gupta R; Singh L; Sharma A; Bagga A; Agarwal SK; Dinda AK Indian J Pathol Microbiol; 2011; 54(3):497-500. PubMed ID: 21934209 [TBL] [Abstract][Full Text] [Related]
29. Clinical and pathological study on patients with primary antineutrophil cytoplasmic autoantibody-associated vasculitis with renal immune complex deposition. Li X; Zhang W; Yu HJ; Pan XX; Shen PY; Ren H; Wang WM; Chen N J Clin Rheumatol; 2015 Jan; 21(1):3-9. PubMed ID: 25539426 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis. Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066 [TBL] [Abstract][Full Text] [Related]
31. Rapidly progressive glomerulonephritis in children. Moorani KN; Aziz M; Amanullah F Pak J Med Sci; 2022 Jan; 38(2):417-425. PubMed ID: 35310798 [TBL] [Abstract][Full Text] [Related]
32. Etiological Spectrum and Clinical Features in 215 Patients of Crescentic Glomerulonephritis: Is it Different in India? Gupta A; Agrawal V; Kaul A; Verma R; Jain M; Prasad N; Pandey R Indian J Nephrol; 2021; 31(2):157-162. PubMed ID: 34267438 [TBL] [Abstract][Full Text] [Related]
33. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Hedger N; Stevens J; Drey N; Walker S; Roderick P Nephrol Dial Transplant; 2000 Oct; 15(10):1593-9. PubMed ID: 11007827 [TBL] [Abstract][Full Text] [Related]
34. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. Cohen BA; Clark WF Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347 [TBL] [Abstract][Full Text] [Related]
35. 'Pauci-immune' rapidly progressive glomerulonephritis associated with systemic vasculitis. Han JY; Yoon SA; Woo JY; Park IS; Kim SY; Chang YS; Bang BK J Korean Med Sci; 1992 Sep; 7(3):264-70. PubMed ID: 1285926 [TBL] [Abstract][Full Text] [Related]
36. Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Little MA; Nazar L; Farrington K Nephrol Dial Transplant; 2004 Feb; 19(2):356-64. PubMed ID: 14736959 [TBL] [Abstract][Full Text] [Related]
37. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors. Gallan AJ; Alexander E; Reid P; Kutuby F; Chang A; Henriksen KJ Am J Kidney Dis; 2019 Dec; 74(6):853-856. PubMed ID: 31204194 [TBL] [Abstract][Full Text] [Related]
38. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis. Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334 [TBL] [Abstract][Full Text] [Related]
39. Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study. Chalkia A; Thomas K; Giannou P; Panagiotopoulos A; Hadziyannis E; Kapota A; Gakiopoulou H; Vassilopoulos D; Petras D Ren Fail; 2020 Nov; 42(1):845-852. PubMed ID: 32787590 [TBL] [Abstract][Full Text] [Related]
40. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria. Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK Ren Fail; 2018 Nov; 40(1):554-560. PubMed ID: 30278797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]